Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rang in Aktien #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Aktienkurs
$240.45
Marktkapitalisierung
$579.46B
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
46.88%
Land
US
Handel Johnson & Johnson (JNJ)

Kategorie

Operative Marge für Johnson & Johnson (JNJ)
Operative Marge zum March 2026 TTM: 27.17%
Laut den neuesten Finanzberichten und dem Aktienkurs von Johnson & Johnson beträgt die aktuelle operative Marge (TTM) 27.17%. Am Ende des Jahres 2024 lag die operative Marge bei 24.94%.
Historie der operativen Marge von Johnson & Johnson von 2000 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 27.17% 0.00%
2025 27.17% 8.94%
2024 24.94% -9.28%
2023 27.49% 3.35%
2022 26.60% 11.34%
2021 23.89% -6.50%
2019 25.55% -1.58%
2018 25.96% 5.02%
2017 24.72% -5.29%
2016 26.10% -8.23%
2014 28.44% 7.00%
2013 26.58% 4.89%
2012 25.34% -5.59%
2011 26.84% -0.30%
2010 26.92% 6.15%
2008 25.36% 1.85%
2007 24.90% -3.15%
2006 25.71% -1.49%
2005 26.10% 0.50%
2003 25.97% -2.59%
2002 26.66% 9.26%
2001 24.40% 7.58%
2000 22.68% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
45.56% -98.32%
US
26.72% -99.02%
US
31.24% -98.85%
CH
23.28% -99.14%
GB
41.19% -98.48%
US
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.